Each. Day. Matters.

ZULRESSO (brexanolone) is the first and only FDA-approved medicine specifically for postpartum depression in adults.

When about 1 in 9 moms suffers from postpartum depression (PPD),

Not actual patients.

Postpartum depression is treatable

You may feel as though something isn't quite right. After all, having a baby can be one of the happiest times in one's life. But during pregnancy and after giving birth, some women suffer from a medical condition known as postpartum depression (PPD).

PPD is one of the most common medical complications during and after pregnancy. It is important to take care of yourself because experiencing symptoms of PPD may have consequences. You should know that PPD is treatable with your doctor's help.

You don't have to push through it—talk to your doctor as soon as possible if you think you may have PPD.

You can feel better in 2.5 days with ZULRESSO.

In clinical studies, moms who took ZULRESSO experienced a greater improvement in symptoms of postpartum depression vs placebo in 2.5 days. Symptoms were measured at the beginning of treatment using a standard depression scale and again at the end of treatment.

Because of the risk of serious harm resulting from excessive sedation or sudden loss of consciousness during treatment, ZULRESSO is only available through a restricted program called the ZULRESSO REMS, in which a healthcare provider will carefully monitor the patient at a certified healthcare facility.